
Frithvir 0.5mg Tablet
Marketer
La Renon Healthcare Pvt Ltd
Salt Composition
Entecavir (0.5mg)
Overview Frithvir 0.5mg Tablet
Hepatitis B (HBV) infection is treated with the antiviral agent entecavir, marketed as Frithvir 0.5mg Tablet. Its mechanism involves suppressing HBV replication, thus lowering viral load and mitigating liver damage progression. Administer this medication on an empty stomach, adhering precisely to your physician's prescribed dosage and duration. Consistent adherence optimizes efficacy, improving liver function and minimizing HBV-related complications. However, Frithvir's impact on liver cancer or cirrhosis risk remains undetermined. Continuous use, as directed by your doctor, is crucial; do not interrupt treatment prematurely. Headache, nausea, vomiting, abdominal discomfort, tiredness, and diarrhea are common, generally mild side effects. Report any persistent or bothersome symptoms to your healthcare provider. Rare instances of skin reactions or liver injury necessitate close medical monitoring, particularly during initial treatment. Prior to commencing therapy, disclose any pre-existing skin conditions or kidney disease. Regular blood tests will monitor blood cell counts and liver health. Alcohol consumption should be avoided due to increased liver damage risk. Pregnant or lactating individuals should seek medical counsel before use. If HIV-positive, abstain from unprotected sex and sharing personal items (razors, toothbrushes); discuss safe sex practices with your doctor to prevent HIV transmission.
Uses of Frithvir 0.5mg Tablet
Persistent infection with the hepatitis B virus (HBV)
Major Benefits of Frithvir 0.5mg Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Frithvir 0.5mg Tablet on an empty stomach.
Common Side effects of Frithvir 0.5mg Tablet:
- Headache
- Nausea
- Vomiting
- Fatigue
- Stomach pain
- Diarrhea
How to use Frithvir 0.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Frithvir 0.5mg Tablet on an empty stomach.
How Frithvir 0.5mg Tablet works:
Virex 0.5mg tablets offer antiviral action, inhibiting viral replication within human cells. This halts further virus production, thereby resolving the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Frithvir 0.5mg Tablet lacks established safety data. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Frithvir 0.5mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against potential hazards prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Frithvir 0.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Frithvir 0.5mg Tablet may cause drowsiness, blurred vision, dizziness, and reduced alertness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Frithvir 0.5mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Frithvir 0.5mg tablets pose no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Frithvir 0.5mg Tablet :
Should you forget a Frithvir 0.5mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Frithvir 0.5mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Base analog |
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
| Behavioral Class | Reverse transcriptase inhibitors (RTIs) that are nucleosides or nucleotides |
